U.S. District Court Invalidates Kaneka's Ubiquinol Patent, Clearing the Way for Cocrystal Tech's CrysQnol™ in the U.S. Market

Cocrystal Technology announced that a U.S. District Court overturned Kaneka's '080 patent on grounds of lack of utility and enablement. The ruling removes a key legal uncertainty for Cocrystal Tech's customers and partners and is positive for the company's freedom to operate, though the article excerpt provides no financial damages, sales impact, or broader market details.